Universe Pharmaceuticals (UPC) Change in Account Payables (2020 - 2024)

Universe Pharmaceuticals has disclosed Change in Account Payables across 5 years of filings, most recently posting $7.8 million for Q1 2024.

• Change in Account Payables for Q1 2024 came in at $7.8 million, down 30.92% year-over-year; the trailing twelve-month figure through Mar 2024 was $7.8 million (down 30.92% YoY), and the FY2025 annual result was -$3.1 billion, down 2279.32% from the prior year.
• Change in Account Payables came in at $7.8 million for Q1 2024 at Universe Pharmaceuticals, up from $4.6 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2691.2 billion in Q3 2020 to a low of $3.1 million in Q3 2022.
• The 5-year median for Change in Account Payables is $5.3 million (2021), against an average of $384.5 billion.
• Across the five-year window, Change in Account Payables sank 100.0% in 2021 and soared 208.3% in 2023, its largest moves.
• Universe Pharmaceuticals' Change in Account Payables stood at $2691.2 billion in 2020, then tumbled by 100.0% to $5.3 million in 2021, then plunged by 42.09% to $3.1 million in 2022, then jumped by 49.1% to $4.6 million in 2023, then soared by 69.32% to $7.8 million in 2024.
• The last three Change in Account Payables figures came in at $7.8 million (Q1 2024), $4.6 million (Q3 2023), and $11.2 million (Q1 2023), per Business Quant data.